Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice

Archives of Pharmacal Research

Volumn 32, Issue 9, 2009, Pages 1293-1299

  Can, Özgür Devrim ^a   Özkay, Ümide Demir ^a   KaplancIklI, Zafer Asim ^a   Öztürk, Yusuf ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Activity cage; Antidepressant; Hole board; Modified forced swimming test; Pyrazoline; Swimming

Indexed keywords

ANTIDEPRESSANT AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; FLUOXETINE; PYRAZOLINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CLIMBING; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG SYNTHESIS; EXPLORATORY BEHAVIOR; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MOUSE; NONHUMAN;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; EXPLORATORY BEHAVIOR; MICE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349560117     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1915-5     Document Type: Article

References (36)

1. J. H. Ahn H. M. Kim S. H. Jung S. K. Kang K. R. Kim S. D. Rhee S. D. Yang H. G. Cheon S. S. Kim 2004 Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents Bioorg. Med. Chem. Lett. 14 4461 4465 15357972 10.1016/j.bmcl.2004.06.046 1:CAS:528:DC%2BD2cXmt1Kitbk%3D (Pubitemid 39043967)
2. M. Akhtar K. K. Pillai D. Vohora 2005 Effect of thioperamide on modified forced swimming test-induced oxidative stress in mice Basic Clin. Pharmacol. Toxicol. 97 218 221 16176556 10.1111/j.1742-7843.2005.pto-140.x 1:CAS:528:DC%2BD2MXhtFantb7N (Pubitemid 41433694)
3. E. Aksoz T. Aksoz S. S. Bilge F. Ilkaya S. Celik H. B. Diren 2008 Antidepressant-like effects of echo-planar magnetic resonance imaging in mice determined using the forced swimming test Brain Res. 1236 194 199 18755160 10.1016/j.brainres.2008.08.011 1:CAS:528:DC%2BD1cXht1SitL%2FF
4. A. A. Bilgin E. Palaska R. Sunal 1993 Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines Arzneimittelforsch. 43 1041 1044 8267665 1:CAS:528:DyaK2cXhsFaqtb4%3D (Pubitemid 23311876)
5. F. Chimenti A. Bolasco F. Manna D. Secci P. Chimenti A. Granese O. Befani P. Turini R. Cirilli F. La Torre S. Alcaro F. Ortuso T. Langer 2006 Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)- pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors Curr. Med. Chem. 13 1411 1428 16719786 10.2174/092986706776872907 1:CAS:528:DC%2BD28XlsVGqtLk%3D
6. J. F. Cryan A. Markou I. Lucki 2002 Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 238 245 12008002 10.1016/S0165-6147(02)02017-5 1:CAS:528:DC%2BD38XjsVWjsbo%3D (Pubitemid 34465544)
7. M. J. Detke I. Lucki 1996 Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth Behav. Brain Res. 73 43 46 8788475 10.1016/0166-4328(96)00067-8 1:STN:280:DyaK28zotVClsA%3D%3D (Pubitemid 26007585)
8. J. L. Devoize F. Rigal A. Eschalier J. F. Trolese M. Renoux 1984 Influence of naloxone on antidepressant drug effects in the forced swimming test in mice Psychopharmacology (Berl). 84 71 75 10.1007/BF00432028 1:CAS:528:DyaL2cXmtVChsrk%3D
9. M. Fiore E. Alleva R. Moroni L. Aloe 1998 Infection with Schistosoma mansoni in mice induces changes in nociception and exploratory behavior Physiol. Behav. 65 347 353 9855486 10.1016/S0031-9384(98)00171-1 1:CAS:528: DyaK1cXnvVems7g%3D (Pubitemid 28548658)
10. Gok, S., Demet, M. M., Özdemir, A., and Turan-Zitouni, G., Evaluation of antidepressant-like effect of 2-pyrazoline derivatives. Med. Chem. Res. doi: 10.1007/s00044-009-9176-x.
11. N. Gökhan A. Yepilada G. Uçar K. Erol A. Bilgin 2003 A., 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: Synthesis and evaluation as MAO inhibitors Arch. Pharm. 336 362 371 10.1002/ardp.200300732 (Pubitemid 37127992)
12. N. Gökhan-Kelekçi S. Koyunoolu S. Yabanoolu K. Yelekçi O. Ozgen G. Uçar K. Erol E. Kendi A. Yepilada 2009 New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity Bioorg. Med. Chem. 17 675 689 19091581 10.1016/j.bmc.2008.11.068
13. V. Jayaprakash B. N. Sinha G. Ucar A. Ercan 2008 Pyrazoline-based mycobactin analogues as MAO-inhibitors Bioorg. Med. Chem. Lett. 18 6362 6368 18980841 10.1016/j.bmcl.2008.10.084 1:CAS:528:DC%2BD1cXhsVWjs7bO
14. Z. A. Kaplanclkll G. Turan-Zitouni A. Ozdemir O. Devrim Can P. Chevallet 2009 Synthesis and antinociceptive activities of some pyrazoline derivatives Eur. J. Med. Chem. 44 2606 2610 10.1016/j.ejmech.2008.09.002
15. M. S. Karthikeyan B. S. Holla N. S. Kumari 2007 Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines Eur. J. Med. Chem. 42 30 36 17007964 10.1016/j.ejmech.2006.07.011 1:CAS:528:DC%2BD2sXhsFyku7w%3D (Pubitemid 46198987)
16. S. E. Kennedy R. A. Koeppe E. A. Young J. K. Zubieta 2006 Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women Arch. Gen. Psychiatry. 63 1199 1208 17088500 10.1001/archpsyc.63.11.1199 1:CAS:528:DC%2BD28XhtlSksL%2FP
17. Y. Nakatomi C. Yokoyama S. Kinoshita D. Masaki H. Tsuchida H. Onoe K. Yoshimoto K. Fukui 2008 Serotonergic mediation of the antidepressant-like effect of the green leaves odor in mice Neurosci Lett. 436 167 170 18378079 10.1016/j.neulet.2008.03.013 1:CAS:528:DC%2BD1cXkvVyitrY%3D
18. R. Navinés R. Martín-Santos E. Gómez-Gil M. J. Martínez de Osaba C. Gastó 2008 Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response Prog. Neuropsychopharmacol. Biol. Psychiatry. 32 1804 1809 18725263 10.1016/j.pnpbp.2008.07.021
19. G. Ouyang X. J. Cai Z. Chen B. A. Song P. S. Bhadury S. Yang L. H. Jin W. Xue D. Y. Hu S. Zeng 2008 Synthesis and antiviral activities of pyrazole derivatives containing an oxime moiety J. Agric. Food Chem. 56 10160 10167 18939848 10.1021/jf802489e 1:CAS:528:DC%2BD1cXht1OjtbvF
20. Z. Ozdemir H. B. Kandilci B. Gümüpel U. Calip A. A. Bilgin 2007 Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives Eur. J. Med. Chem. 42 373 379 17069933 10.1016/j.ejmech.2006.09.006 (Pubitemid 46349364)
21. Z. Ozdemir H. B. Kandilci B. Gumusel U. Calis A. A. Bilgin 2008 Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl)pyrazoline derivatives Arch. Pharm. (Weinheim). 341 701 707 10.1002/ardp.200800068 1:CAS:528:DC%2BD1cXhsVOgsrbI
22. A. Özdemir G. Turan-Zitouni Z. A. Kaplanclkll 2008 Novel analogues of 2-pyrazoline: synthesis, characterization, and antimycobacterial evaluation Turk. J. Chem. 32 529 538
23. E. Palaska M. Aytemir I. T. Uzbay D. Erol 2001 Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines Eur. J. Med. Chem. 36 539 543 11525844 10.1016/S0223-5234(01)01243-0 1:CAS:528:DC%2BD3MXmt12nsb8%3D (Pubitemid 32781717)
24. S. S. Parmar B. R. Pandey C. Dwivedi R. D. Harbison 1974 Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines J. Pharm. Sci. 63 1152 1155 4850598 10.1002/jps.2600630730 1:CAS:528:DyaE2MXisF2lsg%3D%3D
25. Y. Rajendra Prasad A. Lakshmana Rao L. Prasoona K. Murali P. Ravi Kumar 2005 Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2-hydroxy naphthalen-1-yl)-1,5-diphenyl-2-pyrazolines Bioorg. Med. Chem. Lett. 15 5030 5034 16168645 10.1016/j.bmcl.2005.08.040 1:STN:280: DC%2BD2MrivVehuw%3D%3D (Pubitemid 41400179)
26. I. G. Rathish K. Javed S. Ahmad S. Bano M. S. Alam K. K. Pillai S. Singh V. Bagchi 2009 Synthesis and anti-inflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide Bioorg. Med. Chem. Lett. 19 255 258 19010670 10.1016/j.bmcl.2008.10.105 1:CAS:528:DC%2BD1MXlvFOk
27. N. Soni K. Pande R. Kalsi T. K. Gupta S. S. Parmar J. P. Barthwal 1987 Inhibition of rat brain monoamine oxidase and succinic dehydrogenase by anticonvulsant pyrazolines Res. Commun. Chem. Pathol. Pharmacol. 56 129 132 3589148 1:CAS:528:DyaL2sXksFWrsL0%3D
28. Z. Tabarelli M. A. Rubin D. B. Berlese P. D. Sauzem T. P. Missio M. V. Teixeira A. P. Sinhorin M. A. P. Martins N. Zanatta H. G. Bonacorso C.F. Mello 2004 Antinociceptive effect of novel pyrazolines in mice Braz. J. Med. Biol. Res. 37 1531 1540 15448875 10.1590/S0100-879X2004001000013 1:CAS:528: DC%2BD2cXps1ykurY%3D
29. H. Takeda M. Tsuji T. Matsumiya 1998 Changes in headdipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice Eur. J. Pharmacol. 350 21 29 9683010 10.1016/S0014-2999(98)00223-4 1:CAS:528:DyaK1cXjvVSlsb0%3D (Pubitemid 28288304)
30. M. Tanaka G. Telegdy 2008 Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of Urocortin 3 in a modified forced swimming test in mice Brain Res. Bull. 77 301 305 10.1016/j.brainresbull.2008. 08.012 1:CAS:528:DC%2BD1cXht1Khu7bO
31. P. Tejedor-Real J. A. Micó R. Maldonado B. P. Roques J. Gibert-Rahola 1995 Implication of endogenous opioid system in the learned helplessness model of depression Pharmacol. Biochem. Behav. 52 145 152 7501657 10.1016/0091-3057(95)00067-7 1:CAS:528:DyaK2MXntlCrsLo%3D
32. G. Ucar N. Gokhan A. Yesilada A. A. Bilgin 2005 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases Neurosci. Lett. 382 327 331 15925113 10.1016/j.neulet.2005. 03.028 1:CAS:528:DC%2BD2MXltVems7w%3D (Pubitemid 40733646)
33. M. Votava L. Hess J. Slíva M. Krsiak V. Agová 2005 Dexmedetomidine selectively suppresses dominant behavior in aggressive and sociable mice Eur. J. Pharmacol. 523 79 85 16226250 10.1016/j.ejphar.2005.08.022 1:CAS:528:DC%2BD2MXhtFKntbfO (Pubitemid 41562381)
34. A. X. Wang Q. Xie B. Lane K. W. Mollison G. C. Hsieh K. Marsh M. P. Sheets J. R. Luly M. J. Coghlan 1998 Synthesis and immunosuppressant activity of pyrazole carboxamides Bioorg. Med. Chem. Lett. 8 2787 2792 9873623 10.1016/S0960-894X(98)00501-0 1:CAS:528:DyaK1cXntFSiurY%3D (Pubitemid 28496671)
35. A. Zangen R. Nakash I. Roth-Deri D. H. Overstreet G. Yadid 2002 Impaired release of â-endorphin in response to serotoninin a rat model of depression Neurosciences 110 389 393 10.1016/S0306-4522(01)00612-1 1:CAS:528:DC%2BD38XitFWitLY%3D (Pubitemid 34242769)
36. V. Zsoldos-Mády A. Csámpai R. Szabó E. Mészáros-Alapi J. Pásztor F. Hudecz P. Sohár 2006 Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines Chem. Med. Chem. 1 1119 1125 16944543